Floatz logo

Folic Acid

Immunosuppression

Fakultas Kedokteran Universitas IndonesiaSmall moleculePhase 4 / ApprovedDormant
BB
68/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Immunosuppression cohort.

Asset / SponsorPhaseRating
ZINC SULFATE
Fakultas Kedokteran Universitas Indonesia
Phase 4BB
Hydroxyurea
Fakultas Kedokteran Universitas Indonesia
Phase 4BB
CYCLOSPORIN A
West China Hospital
Phase 4B
Monomethyl Fumarate
West China Hospital
Phase 4B
Histamine
Sahlgrenska University Hospital
Phase 2CCC
TACROLIMUS
Shanghai Jiao Tong University School of Medicine
N/AD
Basiliximab
Shanghai Jiao Tong University School of Medicine
N/AD

Same molecule, other indications

Folic Acid is also rated in:

hyperhomocysteinemiaDormant
BBB
Indicative ·
76 / 100
View asset →
myocardial infarctionDormant
BBB
Indicative ·
72 / 100
View asset →
polycystic ovary syndromeDormant
BB
Indicative ·
70 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →